Kenneth Hoberman

CIK 1573722 · Chief Operating Officer · last filed 2026-06-15

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$18.69M

Companies

3

Total Filings

55

Lifetime Open-Market Net

-$5.46M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TGTX Director 279,653 $54.33 $15.19M $0 12 2026-06-15
NVCT Director 168,140 $20.79 $3.50M $104.4K 6 2026-06-12
STEMLINE THERAPEUTICS INC (STML) Delisted Chief Operating Officer 0 -$5.56M 37 2020-06-10

Recent Filings · Page 5 of 6

55 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2017-02-17 STEMLINE THERAPEUTICS INC (STML) Delisted Sell (S) −1,508 -$9.7K EDGAR
2017-01-13 STEMLINE THERAPEUTICS INC (STML) Delisted Sell (S) −9,110 -$125.9K EDGAR
2016-07-08 TGTX Grant (A) +12,459 $0 EDGAR
2016-03-10 STEMLINE THERAPEUTICS INC (STML) Delisted Sell (S) −2,412 -$12.9K EDGAR
2016-02-26 STEMLINE THERAPEUTICS INC (STML) Delisted Grant (A) +87,985 $0 EDGAR
2016-02-19 STEMLINE THERAPEUTICS INC (STML) Delisted Sell (S) −1,503 -$6.8K EDGAR
2016-01-11 STEMLINE THERAPEUTICS INC (STML) Delisted Grant (A) +150,000 $0 EDGAR
2015-12-31 STEMLINE THERAPEUTICS INC (STML) Delisted Gift (G) −60,000 $0 EDGAR
2015-06-05 TGTX Grant (A) +4,667 $0 EDGAR
2015-03-20 STEMLINE THERAPEUTICS INC (STML) Delisted Mixed +9,798 -$173.5K EDGAR
Showing 4150 of 55
Page 5 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.